Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma
Clinical trial NCT01090921 · COMPLETED
Trial details
- NCT number
- NCT01090921
- Sponsor
- Boston VA Research Institute, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2015-03-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.